Advertisement
Home Tags CORO

Tag: CORO

For Spanish Translation

Rare Cases of COVID-19 Relapse Seen With Pfizer Pill

0

Reports of symptoms returning in patients several days after completing the five-day regimen of Paxlovid

mRNA Vaccine More Effective Booster to ChAdOx1 nCoV-19

Company Hid Problems With COVID-19 Vaccines From FDA

0

Nearly 400 million doses of vaccine made by Emergent had to be destroyed 'due to poor quality control'

Treatment

Serious Neurologic Manifestations Tied to Worse COVID-19 Outcomes

0

Encephalopathy was the most common serious neurologic manifestation, occurring in 10.2 percent of adults hospitalized with COVID-19

Persistent Fatigue Prevalent After COVID-19 Infection

COVID-19 Drug Paxlovid Might Also Fight Long COVID

0

Series of case reports shows some success with Paxlovid in treating patients with long COVID

Admission Less Likely for COVID-19 Patients With Omicron Versus Delta

0

No significant difference seen in cycle threshold values based on variant, regardless of vaccination status

Moderna CEO Says Fourth COVID-19 Dose May Be Needed Next Fall

FDA Limits Use of J&J COVID-19 Vaccine Due to Blood Clot Risk

0

With safer two-dose vaccines such as Pfizer and Moderna widely available, the one-dose J&J shot should be limited

Neighborhoods Affected by Structural Racism Face Risk for Preterm Births

0

Additionally, pandemic stressors, like unemployment, tied to infections and preterm births

New BA.2 COVID-19 Subvariant Taking Hold in United States

0

Early research suggests that BA.2.12.1 is better able to evade the immune system than previous versions of the coronavirus

WHO Says Pandemic Death Total Far Higher Than Reported in Many Countries

0

Most excess deaths caused by COVID-19; other deaths occurred because pandemic made it more difficult to get medical care

 Could Obesity Blunt the Response to the COVID Vaccine?

Plant-Based Recombinant COVID-19 Vaccine Found to Be Effective

0

Vaccine efficacy ranged from 69.5 percent against symptomatic infection to 78.8 percent against moderate-to-severe disease